Pharmafile Logo
Pharmafocus logo
Advanced Search

diabetes

Showing 15 posts of 391 posts found.

Forxiga image

NICE rejects Forxiga

February 1, 2013
Sales and Marketing AstraZeneca, BMS, Forxiga, NICE, diabetes

NICE has given the thumbs-down to AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga. The drug was approved …

News
Takeda HQ image

Takeda gets US diabetes approval

January 28, 2013
Sales and Marketing FDA, Nesina, Takeda, diabetes

Takeda has been given US approval for its diabetes drug Nesina and two variations on it for the treatment of …

News
janssen image

Janssen’s diabetes drug Invokana recommended

January 11, 2013
Sales and Marketing Janssen, SGLT2, canagliflozin, diabetes, invokana

An FDA advisory committee has recommended Janssen’s new diabetes treatment canagliflozin for approval. To be marketed under the name Invokana, …

News

Boehringer hands back Lilly drug

January 8, 2013
Research and Development, Sales and Marketing Boehringer, Tradjenta, diabetes, lilly

Boehringer Ingelheim has handed back one of Eli Lilly’s investigational diabetes drugs as a result of ‘independent strategic portfolio considerations’. …

News

Sanofi – aiming for number one in the world’s biggest diabetes market

December 18, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, Sanofi, diabetes, obesity

Sanofi is no different from any other major pharma company in seeing China as the single most important growth market …

Feature

Trajenta may reduce stroke damage

December 4, 2012
Research and Development, Sales and Marketing Boehringer, EMA, Trajenta, diabetes, linagliptin

Boehringer Ingelheim’s  diabetes drug Trajenta could one day be used to minimise the effects of brain damage following stroke. Scientists …

News
Forxiga image

Forxiga approved in European Union

November 15, 2012
Sales and Marketing AstraZeneca, BMS, Forxiga, diabetes

AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga has been approved in Europe – a major filip for …

News
sanofi image

Diabetes softens generics blow for Sanofi

October 30, 2012
Sales and Marketing Eloxatin, Plavix, Sanofi, diabetes, emerging markets, patent cliff

Sanofi has unveiled its results for the third quarter, with news that the damage done by patent expiries has not …

News

Trajenta added to insulin recommended in Europe

September 26, 2012
Sales and Marketing Boehringer Ingelheim, Trajenta, diabetes

The CHMP has recommended that Boehringer Ingelheim and Eli Liily and Co’s diabetes brand Trajenta should be approved as add-on …

News

Online programme to help diabetes patients

September 14, 2012
Medical Communications, Sales and Marketing Boehringer, diabetes, lilly

Boehringer Ingelheim and Eli Lilly have launched an online initiative which they say will help diabetes sufferers make simple lifestyle …

News

Boehringer signs diabetes research deal

September 7, 2012
Sales and Marketing Boehringer, diabetes, obesity

Boehringer Ingelheim has signed a four-year research agreement with a top Swiss university to look at the underlying causes of …

News

Charity launches ‘Diabetes App Challenge’

August 21, 2012
Medical Communications apps, diabetes, digital

Diabetes UK has launched its Diabetes App Challenge for younger insulin dependent patients. The Diabetes App Challenge wants people with …

News
Takeda's Actos

Generic Actos gains FDA approval

August 20, 2012
Sales and Marketing Actos, Mylan, Ranbaxy, Takeda, diabetes, generic

Takeda’s big-selling diabetes pill Actos will have its US sales decimated after the FDA approves three copycat versions of the …

News

Diabetes prescriptions jump by 50% in England

August 15, 2012
Sales and Marketing Humalog, Januvia, NHS, diabetes, spending

Diabetes prescriptions in England have for the first time topped 40 million this year, a rise of nearly 50% compared …

News
AZ app image

AstraZeneca launches prostate cancer app

August 7, 2012
Medical Communications AZ, AstraZeneca, PSA, Zoladex, diabetes, prostate

AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026